Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma [EARLY_Phase 1]
An early-phase study evaluating a GPC3-targeted PET imaging agent for hepatocellular carcinoma is currently recruiting to assess its clinica…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma [Phase 1, Phase 2]
This entry describes a Phase 1/2 clinical trial evaluating the safety and efficacy of Tremelimumab plus Durvalumab in combination with trans…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab [Phase 2]
A Phase 2 clinical trial at Chang Gung Memorial Hospital is evaluating hyperpolarized 13C-MRI as a biomarker in hepatocellular carcinoma pat…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating atezolizumab and bevacizumab with photon radiotherapy for unresectable hepatocellular carcinoma is currently recrui…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
Clinical trial evaluating immune responses and clinical outcomes in patients with hepatocellular carcinoma undergoing radiotherapy is curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2025-05-14Clinical Trial Update: SIRT and Peri-immunotherapy : a New Concept
A clinical trial update describes a study of combining selective internal radiation therapy with peri-immunotherapy for advanced hepatocellu…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma
This real-world study evaluates the combination of camrelizumab and apatinib mesylate for unresectable hepatocellular carcinoma and is curre…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma
The clinical trial update describes a radiofrequency-responsive layered double hydroxide approach to enhance arterial embolization and therm…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma [Phase 2, Phase 3]
Clinical trial update on camrelizumab plus apatinib mesylate as perioperative treatment for resectable hepatocellular carcinoma; the study s…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: LEOPARD Training and Validation Data Collection Study
LEOPARD is a training and validation data collection study that is currently recruiting to assemble data for liver disease conditions includ…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy [Phase 3]
Phase 3 trial of atezolizumab plus bevacizumab for unresectable or locoregionally unsuitable hepatocellular carcinoma in Spanish patients ha…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab [NA]
The trial investigates prophylaxis for esophageal and/or gastric varices in patients with hepatocellular carcinoma who are being treated wit…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma [Phase 1]
Phase 1 clinical trial evaluating autologous HBV-TCR T cell therapy LioCyx-M for hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy [Phase 1, Phase 2]
Clinical trial update on safety and efficacy of investigational therapy NMS-01940153E in adults with unresectable hepatocellular carcinoma w…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma
This clinical trial is evaluating whether PIVKA-II can predict portal vein tumor thrombosis in hepatocellular carcinoma and is currently rec…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma
A clinical trial update indicates Fibroscan is being used to evaluate immunotherapy response in hepatocellular carcinoma and the study is cu…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: FMT in IT-refractory HCC - FAB-HCC Pilot Study [Phase 2]
Phase 2 FAB-HCC Pilot Study completed evaluating fecal microbiota transplant for hepatocellular carcinoma that is refractory to immune thera…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of Recurrence [Phase 2]
Phase 2 trial evaluating the combination of iparomlimab and tuvonralimab (QL1706) with bevacizumab as postoperative adjuvant therapy for hep…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads [Phase 1]
A completed Phase 1 trial evaluating whether contrast-enhanced ultrasound can predict treatment response in hepatocellular carcinoma patient…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer [EARLY_Phase 1]
An early-phase study to assess the safety and feasibility of combining nivolumab with drug-eluting bead transarterial chemoembolization for …
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib [Phase 2]
Phase 2 trial update evaluating sorafenib plus doxorubicin in patients with advanced hepatocellular carcinoma who progressed on sorafenib; t…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells [Phase 1, Phase 2]
Phase 1/2 clinical trial testing delivery of a diuretic into the hepatic artery followed by arterial embolization to starve out unresectable…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating biomarkers related to Beta-catenin activation in non-resectable hepatocellular carcinoma is currently re…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Liver Cancer Registry Platform
A liver cancer registry platform clinical trial sponsored by iOMEDICO AG is currently recruiting for hepatocellular carcinoma and cholangioc…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating CHS-006 in combination with toripalimab for advanced solid tumors, including non-small cell lung cancer, has been…